UPDATE: Jefferies Reiterates Buy Rating, Raises PT on Biomed Realty Trust Following REIT Day

In a report published Wednesday, Jefferies analyst Omotayo Okusanya reiterated a Buy rating on Biomed Realty Trust

, and slightly raised the price target from $24.00 to $25.00. In the report, Okusanya noted, “Management teams expressed confidence in the ability to grow internally as well as externally via accretive acquisitions and development. The outlook for Medicare and Medicaid reimbursement seems benign over the next 12 months which is a positive. In our view, the biggest challenge is valuation, although several names seem set for better than expected FFO/sh growth in 2013.” Biomed Realty Trust closed on Tuesday at $21.56.